Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration

QR Code

Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration

Engin Akyol, Andrew Lotery Clinical Neurosciences Research Group, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UKCorrespondence: Andrew LoteryClinical Neurosciences Research Group, Faculty of Medicine, University of Southampton, Southampton Gene...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Akyol E, Lotery A
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2020
Sujets:	choroidal neovascularisation geographic atrophy gene therapy macular degeneration stem cell therapy monoclonal antibodies Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/662d7e46cea145a9a309137ec7852940
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration
par: Hector SM, et autres
Publié: (2017)

Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review
par: Muste JC, et autres
Publié: (2021)

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
par: Gallemore RP, et autres
Publié: (2017)

Spotlight on reticular pseudodrusen
par: Rabiolo A, et autres
Publié: (2017)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
par: Elfandi S, et autres
Publié: (2021)

Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
par: Jing Wang, et autres
Publié: (2021)

One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement
par: Hirakata T, et autres
Publié: (2016)

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
par: Bhagat D, et autres
Publié: (2020)

Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration
par: Suetsugu T, et autres
Publié: (2016)

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up
par: Yan Lu, et autres
Publié: (2021)

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
par: Fong AH, et autres
Publié: (2013)

To Peel or Not to Peel: Pars Plana Vitrectomy with Macular Membrane Peel in Eyes with Abnormalities of Vitreomacular Interface and Coexisting Dry Age-Related Macular Degeneration
par: Furashova O, et autres
Publié: (2020)

Stem cell therapies for age-related macular degeneration: the past, present, and future
par: Dang Y, et autres
Publié: (2015)

Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes
par: Pedrosa AC, et autres
Publié: (2016)

Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration
par: Balaratnasingam C, et autres
Publié: (2015)

Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
par: Sagong M, et autres
Publié: (2021)

Implantation of the First IMT Macular Lens in Age-Related Macular Degeneration (Literature Review)
par: M. M. Bikbov, et autres
Publié: (2019)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
par: Pongsachareonnont P, et autres
Publié: (2018)

Association Between the Degree of Inclusion of Components Identified on Fluorescein or Indocyanine Green Angiography in Target Spots and Relapse of Exudate in Eyes with Polypoidal Choroidal Vasculopathy and Typical Age-Related Macular Degeneration After Photodynamic Therapy
par: Yoshida I, et autres
Publié: (2021)

Comparison of choroidal neovascularization secondary to white dot syndromes and age-related macular degeneration by using optical coherence tomography angiography
par: Wang JC, et autres
Publié: (2018)

Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye
par: Sarezky D, et autres
Publié: (2016)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
par: Suzuki H, et autres
Publié: (2017)

A Potential New Role for Zinc in Age-Related Macular Degeneration through Regulation of Endothelial Fenestration
par: Fiona Cunningham, et autres
Publié: (2021)

Real-World Outcomes of Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: A Large-Scale Postmarketing Surveillance in Korea
par: Ryu G, et autres
Publié: (2021)

Management of neovascular age-related macular degeneration: Taiwan expert consensus
par: Ling Yeung, et autres
Publié: (2021)

Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration
par: Cotrim CC, et autres
Publié: (2017)

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
par: Sakamoto S, et autres
Publié: (2018)

Medication Trends for Age-Related Macular Degeneration
par: Yeon-Kyoung Cho, et autres
Publié: (2021)

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome
par: Chung WH, et autres
Publié: (2016)

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
par: Takahashi K, et autres
Publié: (2018)

The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration
par: I-Chia Liang, et autres
Publié: (2021)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
par: Kabanarou SA, et autres
Publié: (2017)

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
par: Azuma K, et autres
Publié: (2018)

Treatment of large avascular retinal pigment epithelium detachments in age-related macular degeneration with aflibercept, photodynamic therapy, and triamcinolone acetonide
par: Tvenning AO, et autres
Publié: (2019)

Features of IgG-antibodies production to individual Cytomegalovirus proteins in various eye diseases (age-related macular degeneration and central serous chorioretinopathy)
par: V. V. Neroev, et autres
Publié: (2021)

Acquired Vitelliform Macular Degeneration: Characteristics and Challenges of Managing Subretinal Fluid
par: Joseph Juliano, et autres
Publié: (2021)

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK
par: Hykin P, et autres
Publié: (2016)

Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma
par: Jacek Dziedziak, et autres
Publié: (2021)

Optimized Prediction Models from Fundus Imaging and Genetics for Late Age-Related Macular Degeneration
par: Arun Govindaiah, et autres
Publié: (2021)

Slowed Progression of Age-Related Geographic Atrophy Following Subthreshold Laser
par: Luttrull JK, et autres
Publié: (2020)